Overview
Ilinca Prisacaru is a primary care provider, practicing in Family Medicine in Pell City, Alabama. Dr. Prisacaru is rated as an Experienced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Folate Deficiency, Vitamin B12 Deficiency Anemia, Multiple Carboxylase Deficiency, Hypertension, and Endoscopy. Dr. Prisacaru is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- MEDICARE MAPD
- MEDICARE PDP
- INSURANCE PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
Accepted plan types not found. Please verify directly with the provider.
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
41 Eminence Way, Suite A, Pell City, AL 35128
125 Jeffrey Wilson Dr, Odenville, AL 35120
Prime Healthcare Services-Gadsden Physician Management LLC
James Robinson is a primary care provider, practicing in Family Medicine in Gadsden, Alabama. Dr. Robinson is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Maturity Onset Diabetes of the Young, Acute Cystitis, Sitosterolemia, and Type 2 Diabetes (T2D). Dr. Robinson is currently accepting new patients.
Sand Mountain Family Practice Center, P. C.
Michael Peters is a primary care provider, practicing in Family Medicine in Albertville, Alabama. Dr. Peters is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Familial Combined Hyperlipidemia, Xanthoma, Cirrhosis, and High Cholesterol. Dr. Peters is currently accepting new patients.
Premier Family Care Arab LLC
Jess Youngblood is a primary care provider, practicing in Family Medicine and General Practice in Arab, Alabama. Dr. Youngblood is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Tracheitis, Hypertension, Familial Hypertension, and Glucocorticoid-Remediable Aldosteronism. Dr. Youngblood is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Atypical PneumoniaDr. Prisacaru isExperienced. Learn about Atypical Pneumonia.
- CellulitisDr. Prisacaru isExperienced. Learn about Cellulitis.
- Chronic Obstructive Pulmonary Disease (COPD)Dr. Prisacaru isExperienced. Learn about Chronic Obstructive Pulmonary Disease (COPD).
- Chronic PainDr. Prisacaru isExperienced. Learn about Chronic Pain.
- Colonic MalakoplakiaDr. Prisacaru isExperienced. Learn about Colonic Malakoplakia.
- COVID-19Dr. Prisacaru isExperienced. Learn about COVID-19.